Leukemias

Clinical Obstetrics and Gynecology

Volumn 45, Issue 3, 2002, Pages 866-878

  Pejovic, Tanja ^a   Schwartz, Peter E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALKYLATING AGENT; ALLOPURINOL; ALUMINUM HYDROXIDE; ANTHRACYCLINE DERIVATIVE; ANTIBIOTIC AGENT; ANTILEUKEMIC AGENT; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; ASPARAGINASE; BICARBONATE; CATION EXCHANGE RESIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FOLIC ACID DERIVATIVE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GYRASE INHIBITOR; LOMUSTINE; MERCAPTOPURINE; METHOTREXATE; PROCARBAZINE; STEROID; TENIPOSIDE; UNINDEXED DRUG; VANCOMYCIN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GENETICS; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DEPRESSION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; FATIGUE; FEBRILE NEUTROPENIA; GOUT; HEART ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPERURICEMIA; IMMUNOPHENOTYPING; INFECTION; INFERTILITY; KIDNEY FAILURE; LEUKOPENIA; MUCOSA INFLAMMATION; OVARY FOLLICLE ATRESIA; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; SIDE EFFECT; TERATOGENICITY;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; THROMBOCYTOPENIA;

EID: 0036403715     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200209000-00033     Document Type: Review

References (59)

1. Hernandez JA, Land KJ, McKenna RW. Leukemia, myeloma, and other lymphoreticular neoplasms. Cancer. 1995;75:381-389.
2. Aisenberg AC. Acute nonlymphocytic leukemia after treatment for Hodgkin's disease. Am J Med. 1983;75:449-543.
3. Pui CH, Behm FG, Raimondi SC, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med. 1989;321:136-140.
4. Detourmignies I, Castaigne S, Stoppa AM, et al. Therapy-related acute promyelocytic leukemia: A report on 16 cases. J Clin Oncol. 1992;10:1430-1436.
5. Curtis RE, Boice JR, Stovall M, et al. Risk of leukemia after chemotherapy and radiation for ovarian cancer. N Engl J Med. 1992;326:1745-1749.
6. Kaldor JM, Day NE, Pettersson F, et al. Leukemia following chemotherapy for ovarian cancer. N Engl J Med. 1990;322:1-6.
7. Kumar L. Secondary leukemia after autologous bone marrow transplantation. Lancet. 1995;345:810-812.
8. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. III. Leukemia, lymphoma, and multiple myeloma, 1950-1987. Radiat Res. 1994;137: S68.
9. Doll R, Evans HJ, Darby SC. Paternal exposure not to blame. Nature. 1994;367:678-679.
10. Siegel M. Smoking and leukemia: Evaluation of causal hypothesis. Am J Epidemiol. 1993;138:1-9.
11. Kabat GC, Augustine A, Hebert JR. Smoking and adult leukemia: A case-control study. J Clin Epidemiol. 1988;41:97-100.
12. Feychting M, Anders A. Magnetic fields and cancer in children residing near Swedish high-voltage power lines. Am J Epidemiol. 1993;138:467-469.
13. Taubes G. Another blow weakens EMF-cancer link. Science. 1995;269:1816-1817.
14. Austin A, Delzell E, Cole P. Benzene and leukemia: A review of the literature and risk assessment. Am J Epidemiol. 1988;127:419-428.
15. Pui C-H. Childhood leukemias. N Engl J Med. 1995;332:1618-1623.
16. Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the classification of acute leukemias. Br J Haematol. 1976;33:451-457.
17. Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). Ann Intern Med. 1985;103:460-465.
18. Catovsky D, Matutes E, Buccheri V, et al. A classification of acute leukemias for 1990s. Ann Hematol. 1991;62:16-19.
19. Scheinberg DA, Maslak P, Weiss M. Acute leukemias. In De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 6th Ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 2404-2432.
20. Miller WH Jr, Levine K, DeBlasio A, et al. Detection of minimal residual disease in acute promyelocytic leukemia by reverse transcription polymerase chain reaction assay for PML/RAR-alpha fusion mRNA. Blood. 1993;82:1689-1695.
21. Redner A, Hehewisch S, Haimi J, et al. A study of multidrug resistance and cell kinetics in a child with near-haploid acute lymphoblastic leukemia. Leukemia Res. 1990;14:771-778.
22. Freireich EJ, Cork A, Stass SA, et al. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. Leukemia. 1992;6:500-504.
23. Anastasi J, Vardiman JM, Rudinski R, et al. Direct correlation of cytogenetic findings with morphology using in situ hybridization: An analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukemia. Blood. 1991,77:2456-2461.
24. Campana D, Pul C-H. Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood. 1995;85:1416-1434.
25. Appelbaum FR, Downing J, William C. The biology and therapy of acute myelogenous leukemia. Education Program ASH 1995:23-30.
26. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555-560.
27. Scheinberg DA, Maslak P, Weiss M. Acute leukemias. In De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 5th Ed. Philadelphia: Lippincott-Raven, 1997:2293-2320.
28. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290-293.
29. Konopka JB, Watanabe SM, Witte ON. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell. 1984;37:1035-1042.
30. Bolin RW, Robinson WA, Sutherland J, et al. Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia. Cancer. 1982;50:1683-1688.
31. Goldman JM, Szydlo R, Horowitz MM, et al. Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia for chronic phase. Blood. 1993;82:2235-2239.
32. Hehlmann R, Heimpel H, Hasford J, et al. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood. 1994;84:4064-4070.
33. Enright H, McGlave PB. Biology and treatment of chronic myelogenous leukemia. Oncology. 1997;11:1295-1299.
34. Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med. 1994;330:280-288.
35. Appelbaum FR. Perspectives on the future of chronic myeloid leukemia treatment. Semin Hematol. 2001;38:35-42.
36. Boren J, Casante M, Marin S, et al. Gleevec (STI571) influences enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J Biol Chem. 2001;37:747-753.
37. Etienne G, Mahon FX. Leukemogenesis and new therapy development: The example of chronic myelogenous leukemia. Bull Cancer. 2001;88:651-658.
38. Lippman M. Steroid hormone receptors in human malignancy. Life Sci. 1976;18:143-147.
39. American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care, 4th Ed. Elk Grove Village, IL, 2000.
40. Brell J, Kalaycio M. Leukemia in pregnancy. In Trimble EL, Trimble CU. Cancer in Obstetrics and Gynecology. Philadelphia: Lippincott Williams & Wilkins, 1999:177-208.
41. Caligiuri MA. Leukemia and pregnancy: Effects of treatment on mother and child. Adv Oncol. 1992;8:10-17.
42. Sadural E, Smith LG. Hematologic malignancies during pregnancy. Clin Obstet Gynecol. 1995;38:535-546.
43. Dildy GA III, Moise KJ Jr, Karpenter R Jr. Maternal malignancy metastatic to the products of conception: A review. Obstet Gynecol Surv. 1989;44:535-540.
44. Claahsen HL, Semmekrot BA, van Dongen PM, et al. Successful fetal outcome after exposure to doxorubicin and cytosine-arabinoside during the second trimester of pregnancy - A case report. Am J Perinatol. 1998;15:295-297.
45. Weibel KS, Tallman MS. Chronic leukemia. In Gleicher N, ed. Principles and Practice of Medical Therapy in Pregnancy. New York: Appleton & Lange, 1992:1068-1072.
46. Chrisomalis L, Baxi LV, Heller D. Chronic lymphocytic leukemia in pregnancy. Am J Obstet Gynecol. 1996;175:1381-1382.
47. Doll DC, Ringenberg QS, Yarbro JW. Anti-neoplastic agents and pregnancy. Semin Oncol. 1989;16:337-345.
48. Moore KL. The Developing Human: Clinically Oriented Embryology, 4th Ed. Philadelphia: WB Saunders, 1988:38.
49. Jones KL. Effect of therapeutic, diagnostic, and environmental agents. In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice, 4th Ed. Philadelphia: WB Saunders, 1999:132-150.
50. Elliot JP. Massive fetomaternal hemorrhage treated by fetal intravascular transfusion. Obstet Gynecol. 1991;78:520-523.
51. Mc McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. 1985;312:82-85.
52. Creasy RK, Resnik R. Intrauterine growth restriction. In Creasy RK, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice, 4th Ed. Philadelphia: WB Saunders, 1999:569-576.
53. Read EJ, Platzer PB. Placental metastasis from maternal carcinoma of the lung. Obstet Gynecol. 1981;58:387-391.
54. Juarez S, Cuadradi Pastor JM, Feliu J. Association of leukemia and pregnancy: Clinical and obstetric aspects. Am J Clin Oncol. 1988;11:159-164.
55. Bassan R. The management of infections in patients with leukemia. In Henderson ES, Lister TA, Greaves MF, eds. Leukemia, 6th Ed. Philadelphia: WB Saunders, 1996:257-266.
56. Honore LH, Brown LB. Intervillous placental metastasis with maternal myeloid leukemia. Arch Pathol Lab Med. 1990;114:450-453.
57. Collins JM. Pharmacokinetics and clinical monitoring. In Chabner BA, Longo DL, eds. Cancer Chemotherapy and Biotherapy: Principles and Practice, 2d Ed. Philadelphia: Lippincott-Raven, 1996:17.
58. Zuazu J, Julia A, Sierra J, et al. Pregnancy outcome in hematologic malignancies. Cancer. 1991;67:703-710.
59. Gunz FW, Gunz JP, Veale AMO, et al. Familial leukemia: A study of 909 families. Scand J Haematol. 1975;15:117-124.